According to the microarray data, we identified a positive significance between increasing expression of SHMT2 and recurrent OSCC (Figures 4A,B), and there was no distinct difference in target protein expression among different tumor sizes (Figure 4C), lymph node stages (Figure 4D), and lymph node metastasis (Figure 4E). The gene discussed is SHMT2; the disease is neoplasm.